Xiaoran Ma
- kawaokashinpei3
- 6月1日
- 読了時間: 3分
Selected journal : Science
Mechanical load inhibits cancer growth in mouse and human hearts
What is the main question of the paper?
The main question of this study is to investigate whether the high-intensity mechanical load generated by the continuous beating of the heart serves as a key mechanism for its natural resistance to cancer, including primary tumors and malignant metastases. Also it finds the molecular and epigenetic signal transduction pathways underlying this physical barrier.
How did the anthor address the question?
■Step1
In vivo animal models
The authors first used a genetic mouse model to confirm that the heart naturally resists tumor formation, even when tumors grow in surrounding skeletal muscles. To test if this protection comes from the heartbeat, they performed heterotopic heart transplantation, surgically connecting a donor heart to the neck of a recipient mouse. This procedure kept the transplanted heart alive with blood flow but completely removed the mechanical load inside the left ventricle. The experiment showed that injected lung cancer cells grew very poorly in normal, loaded hearts but multiplied aggressively in unloaded hearts. This proved in a living animal that mechanical forces actively stop cancer growth.
■Step2
In vitro engineered heart tissues
To remove the interference of complex body factors like the immune system, the authors grew artificial engineered heart tissues using rat heart cells. They used adjustable metal braces to change tissue stiffness and simulate different load conditions. They also used a calcium-free medium to create completely static, non-beating control tissues. The results showed that cancer cells grew rapidly in unloaded or static tissues but stopped dividing under a high mechanical load. Mathematical simulations further confirmed that the compressive pressure from the beating tissue is the key driver that directly limits cancer cell division.
■Step3
Molecular and epigenetic mechanisms
The authors used spatial transcriptomics to analyze rare clinical samples of human cardiac metastases. They found that cancer cells inside the heart uniquely turned up genes for histone demethylases. In both human samples and mouse models, the physical pressure of the heart altered the cancer cells' epigenetic state, reducing H3K9me3 methylation and making the chromatin structure less compact. This structural change opened specific DNA regions, which then activated pathways that stop the cell cycle. Finally, the study identified a protein on the cancer cell's nuclear membrane, Nesprin-2, as the main force sensor. Knocking down this gene made the cancer cells blind to physical pressure, allowing them to form large tumors even inside a normally beating heart.
What is the strength of the paper?
It is widely observed that the heart is rarely affected by tumors. Although the heart has an extremely rich blood supply, which theoretically makes it easy for circulating metastatic cancer cells to pass through and seed, it anomalously remains cancer-free. In my view, the most critical strength of this study lies in how it breaks away from conventional thinking, it typically focuses on the immune microenvironment or tumor metabolism and instead takes a unique approach by exploring the cause from a physical and mechanical perspective, using the continuous mechanical load of the heart as a breakthrough point for multi-dimensional validation. Through a combination of in vivo and in vitro experiments alongside micro-scale epigenetic analyses, the study ultimately demonstrates that the mechanical load of the heart triggers chromatin remodeling via the nuclear membrane mechanosensor Nesprin-2, thereby activating cell-cycle arrest pathways and directly inhibiting cancer cell proliferation.
Comment
I found the experimental approach of applying mechanical load to inhibit cancer cell proliferation to be highly innovative. Unraveling this unique mechanism shows great promise, and I see potential for applying these findings to other cancer types and developing entirely new therapeutic strategies for cancers in the future.
Comment by Toshifumi Otsuki
